This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Luigi Caliendo explains the benefits of Robotic Technology to President Vincenzo de Luca. Luigi Caliendo explains the benefits of Robotic Technology to President Vincenzo de Luca. When left untreated, arrhythmias may significantly increase the risk of stroke , heart failure , and sudden cardiac arrest. "The
electrophysiology labs. These reductions in cost and carbon emissions will help shape conversations around the value of medical technology re-use at the annual HeartRhythm Society conference in Boston. I believe they are truly adopting a sense of resource stewardship that is so badly needed in electrophysiology today.
The HeartRhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology. On Thursday, Sept.
The robotic technology represented an entirely novel way to address heartrhythm disorders in a minimally invasive procedure with the benefits of robotic precision and safety. Gery Tomassoni , Director of Electrophysiology at Baptist Health Lexington.
Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results.
electrophysiology labs, and will be participating in the HeartRhythm Society annual meeting, HRS 2024, May 16-19 in Boston, MA. electrophysiology labs. electrophysiology labs, and will be participating in the HeartRhythm Society annual meeting, HRS 2024, May 16-19 in Boston, MA.
milla1cf Tue, 05/21/2024 - 08:00 May 21, 2024 — Stereotaxis , a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has been invited to present at HRS Africa Summit 2024 , scheduled to take place during HeartRhythm Society Scientific Sessions in Boston, Massachusetts.
tim.hodson Mon, 04/21/2025 - 11:18 April 21, 2025 Stereotaxis, a provider of surgical robotics for minimally invasive endovascular intervention, will host a live demonstration of the GenesisX Robotic System at this years HeartRhythm Symposium (HRS), taking place April 24-27 in San Diego, CA.
UC San Diego Health is the first in San Diego to successfully implant the world’s first dual chamber and leadless pacemaker system to help treat people with abnormal heartrhythms. The burst of energy can cause the heart to beat more quickly (in a pacemaker), or it can stop dangerous rapid heartrhythms (in an ICD).
said Nick Spadea-Anello, president, Electrophysiology, Boston Scientific. The FARAPULSE PFA System, however, relies on tissue-selective, non-thermal electric fields to ablate heart tissue and avoid damage to surrounding structures. director of electrophysiology, Mount Sinai Fuster Heart Hospital , New York.
Atrial fibrillation (AF) is the most common arrhythmia worldwide, with increasing prevalence resulting from improved awareness, increased life expectancy, and advances in detection technology.
Early treatment of persistent AF can reduce the risk of blood clots, stroke, and heart failure, and may prevent the disease from becoming permanent. Patients are often treated with AADs as frontline therapy for heartrhythm maintenance, though some can experience adverse effects and limited efficacy. Circulation.
It might have been graduation time in many parts of Boston last weekend, but an electrophysiology family reunion was taking place in the city’s Seaport district, bringing the latest in EP science, technology, and patient care. and leveraging data from nearly as broad of a range of modalities (ECG, imaging, implants, catheter.).
1 For the care of patients with CIEDs on RM, manufacturers should include key stakeholders in the design and development of technologies for RM. 1 In patients with CIEDs on RM, the manufacturer should provide an RM system that is reliable, safe, accurate, and meets the needs of the patient.
24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24
Since it was announced as a Class 1A recommendation in 2015 by the HeartRhythm Society, cardiac remote patient monitoring has become the standard of care for cardiac device patients. Cardiac implantable devices are sophisticated technology that provide both therapy and diagnostics for patients with irregular heartrhythms.
During its Annual Conference, HRS 2024, the HeartRhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). director of electrophysiology, Mount Sinai Fuster Heart Hospital , New York.
The launch of Abbott's Volt PFA system marks a major milestone in the evolution of electrophysiology across Europe and signals we're moving beyond early therapy approaches to new systems that incorporate key physician feedback and clinical insights to optimize PFA therapy," said Prof.
milla1cf Mon, 02/12/2024 - 15:18 February 12, 2024 — BIOTRONIK , a leader in implantable medical device technology, announced today they will solely supply their proprietary DX models for new single-chamber ICD implants moving forward. Journal of Cardiovascular Electrophysiology, Volume 30, Issue 10, October 2019, Pages 1994–2001.
Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiologytechnologies. Our mission to combat complex heartrhythm diseases relies on optimizing interoperability.
Four heartrhythm organizations from around the globe developed the statement. It is also published in HeartRhythm , the official journal of the HRS, Journal of Arrhythmia , the official journal of the APHRS, and Journal of Interventional Cardiac Electrophysiology , the official journal of the LAHRS.
This is the first PFA technology to receive FDA approval and follows the recent European CE (Conformité Européenne) Mark of the PulseSelect PFA system in November. This is the first PFA technology to receive FDA approval and follows the recent European CE (Conformité Européenne) Mark of the PulseSelect PFA system in November.
On January 7, 2024, our cardiac electrophysiology community lost Bruce L. Wilkoff, MD, one of the most impactful and pioneering members of the HeartRhythm Society (HRS). Dr Wilkoff was an innovator in the field of cardiac implantable electronic devices (CIEDs).
2 "CE mark approval of the VARIPULSE Platform represents a significant advance in catheter ablation technology, allowing electrophysiologists to offer patients in Europe pulsed field ablation treatment with real-time integrated 3D mapping,” said Tom De Potter , MD, Associate Director, Cardiovascular Center, OLV Hospital Aalst , Belgium".
Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology at Icahn Mount Sinai. AF is an irregular heartbeat or heartrhythm disorder; 2.7 Patients with AF can undergo a catheter procedure, called catheter ablation, to treat this abnormal heartrhythm. and Harry B.
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content